AGIO

NASDAQ · Biotechnology

Agios Pharmaceuticals Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$32.27

+0.32 (+1.00%)

As of Aug 8, 10:08 PM ET ·

AGIO News1 articles

Agios Pharmaceuticals Jumps on FDA Priority Review for Sickle Cell Drug

Agios Pharmaceuticals shares jumped 14.9% after the FDA accepted its mitapivat application for sickle cell disease with Priority Review, setting a Nov. 1 PDUFA date.